| Active, not recruiting |
: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
: - Stage IA Fallopian Tube Cancer
- Stage IA Ovarian Cancer
- Sta
: 2009-03-05
: - Other: Laboratory Biomarker Analysis
|
| Active, not recruiting |
: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2009-02-05
: - Drug: carboplatin Given IV in
|
| Completed |
: Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2008-12-04
: - Biological: ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
|
| Active, not recruiting |
: Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
: - Ovarian Cancer
- Peritoneal Cancer
- Fallopian Tube Cancer
: 2008-12-02
: Procedure: Tumor collection Tumor collected at the time of planned surgery
|
| Terminated |
: Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2008-09-05
: - Drug: carboplatin Given IV
|
| Recruiting |
: Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
: - Fallopian Tube Clear Cell Adenocarcinoma
- Fallopian Tube Endometrioid Adenocarcinoma
: 2008-07-18
: - Behavioral: Behavioral Dietary Intervention
|
| Completed |
: Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2008-06-19
: - Drug: cisplatin IP cisplatin w
|
| Completed |
: A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
: - Ovarian Neoplasms
- Fallopian Tube Neoplasms
- Peritoneal Neop
: 2008-06-12
: Drug: doxorubicin HCL liposome; bevacizumab; carboplatin 30 mg/m2 by intravenous infusion Day 1 of each
|
| Withdrawn |
: Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2008-06-06
: - Biological: immunological adjuvant OPT-821
|
| Completed |
: Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
: - Primary Peritoneal Cancer
- Advanced Epithelial Ovarian Cancer
: 2008-05-09
: Drug: Iniparib Body weight adjusted dose
|
